Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection

Journal of Virology

Volumn 88, Issue 22, 2014, Pages 13086-13098

  Prasad, Vibhu ^a   Suomalainen, Maarit ^a   Pennauer, Mirjam ^a   Yakimovich, Artur ^a   Andriasyan, Vardan ^a   Hemmi, Silvio ^a   Greber, Urs F ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; GOLGI SPECIFIC BREFELDIN A RESISTANT GUANINE NUCLEOTIDE EXCHANGE FACTOR 1; GOLGICIDE A; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INOSITOL REQUIRING ENZYME 1; NUCLEASE; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; ONCOLYTIC VIRUS;

ADENOVIRUS INFECTION; ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA TRANSFECTION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 5; HUMAN ADENOVIRUS B3; HUMAN CELL; IMPEDANCE; MELANOMA CELL; PROMOTER REGION; REAL TIME LABEL FREE IMPEDANCE; TRANSGENE; UNFOLDED PROTEIN RESPONSE; VIRUS GENE; CELL DEATH; GROWTH, DEVELOPMENT AND AGING; MELANOCYTE; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

CELL DEATH; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; MELANOCYTES; ONCOLYTIC VIRUSES; UNFOLDED PROTEIN RESPONSE;

EID: 84908389414     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02156-14     Document Type: Article

References (74)

1. Chen DS, Mellman I. 2013. Oncology meets immunology: the cancerimmunity cycle. Immunity 39:1-10. http://dx.doi.org/10.1016/j.immuni.2013.07.012.
2. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013.
3. Bell J, McFadden G. 2014. Viruses for tumor therapy. Cell Host Microbe 15:260-265. http://dx.doi.org/10.1016/j.chom.2014.01.002.
4. Russell SJ, Peng KW, Bell JC. 2012. Oncolytic virotherapy. Nat. Biotechnol. 30:658-670. http://dx.doi.org/10.1038/nbt.2287.
5. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J. 2013. Gene therapy clinical trials worldwide to 2012-an update. J. Gene Med. 15:65-77. http://dx.doi.org/10.1002/jgm.2698.
6. Bovenberg MS, Degeling MH, Tannous BA. 2013. Advances in stem cell therapy against gliomas. Trends Mol. Med. 19:281-291. http://dx.doi.org/10.1016/j.molmed.2013.03.001.
7. Touchefeu Y, Franken P, Harrington KJ. 2012. Radiovirotherapy: principles and prospects in oncology. Curr. Pharm. Des. 18:3313-3320. http://dx.doi.org/10.2174/1381612811209023313.
8. Kyula JN, Khan AA, Mansfield D, Karapanagiotou EM, McLaughlin M, Roulstone V, Zaidi S, Pencavel T, Touchefeu Y, Seth R, Chen NG, Yu YA, Zhang Q, Melcher AA, Vile RG, Pandha HS, Ajaz M, Szalay AA, Harrington KJ. 2014. Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-alpha signaling. Oncogene 33:1700-1712. http://dx.doi.org/10.1038/onc.2013.112.
9. Mahoney DJ, Lefebvre C, Allan K, Brun J, Sanaei CA, Baird S, Pearce N, Gronberg S, Wilson B, Prakesh M, Aman A, Isaac M, Mamai A, Uehling D, Al-Awar R, Falls T, Alain T, Stojdl DF. 2011. Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death. Cancer Cell 20: 443-456. http://dx.doi.org/10.1016/j.ccr.2011.09.005.
10. Claude A, Zhao B-P, Kuziemsky CE, Dahan S, Berger SJ, Yan J-P, Armold AD, Sullivan EM, Melançon P. 1999. GBF1: a novel Golgiassociated Bfa-resistant guanine nucleotide exchange factor that displays specificity for Adp-ribosylation factor 5. J. Cell Biol. 146:71-84. http://dx.doi.org/10.1083/jcb.146.1.71.
11. Zhao X, Claude A, Chun J, Shields D, Presley J, Melançon P. 2006. GBF1, a cis-Golgi and VTCs-localized Arf-GEF, is implicated in ER-to-Golgi protein traffic. J. Cell Sci. 119:3743-3753. http://dx.doi.org/10.1242/jcs.03173.
12. Mansour SJ, Herbrick JA, Scherer SW, Melancon P. 1998. Human GBF1 is a ubiquitously expressed gene of the sec7 domain family mapping to 10q24. Genomics 54:323-327. http://dx.doi.org/10.1006/geno.1998.5563.
13. Szul T, Garcia-Mata R, Brandon E, Shestopal S, Alvarez C, Sztul E. 2005. Dissection of membrane dynamics of the Arf-guanine nucleotide exchange factor GBF1. Traffic 6:374-385. http://dx.doi.org/10.1111/j.1600-0854.2005.00282.x.
14. Citterio C, Vichi A, Pacheco-Rodriguez G, Aponte AM, Moss J, Vaughan M. 2008. Unfolded protein response and cell death after depletion of brefeldin A-inhibited guanine nucleotide-exchange protein GBF1. Proc. Natl. Acad. Sci. U. S. A. 105:2877-2882. http://dx.doi.org/10.1073/pnas.0712224105.
15. Greber UF, Arnberg N, Wadell G, Benko M, Kremer EJ. 2013. Adenoviruses- from pathogens to therapeutics: a report on the 10th International Adenovirus Meeting. Cell. Microbiol. 15:16-23. http://dx.doi.org/10.1111/cmi.12031.
16. Wolfrum N, Greber UF. 2013. Adenovirus signalling in entry. Cell. Microbiol. 15:53-62. http://dx.doi.org/10.1111/cmi.12053.
17. Burckhardt CJ, Suomalainen M, Schoenenberger P, Boucke K, Hemmi S, Greber UF. 2011. Drifting motions of the adenovirus receptor CAR and immobile integrins initiate virus uncoating and membrane lytic protein exposure. Cell Host Microbe 10:105-117. http://dx.doi.org/10.1016/j.chom.2011.07.006.
18. Moyer CL, Wiethoff CM, Maier O, Smith JG, Nemerow GR. 2011. Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J. Virol. 85:2631-2641. http://dx.doi.org/10.1128/JVI.02321-10.
19. Suomalainen M, Luisoni S, Boucke K, Bianchi S, Engel DA, Greber UF. 2013. A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J. Virol. 87:12367-12379. http://dx.doi.org/10.1128/JVI.01833-13.
20. Bremner KH, Scherer J, Yi J, Vershinin M, Gross SP, Vallee RB. 2009. Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe 6:523-535. http://dx.doi.org/10.1016/j.chom.2009.11.006.
21. Strunze S, Engelke MF, Wang I-H, Puntener D, Boucke K, Schleich S, Way M, Schoenenberger P, Burckhardt CJ, Greber UF. 2011. Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection. Cell Host Microbe 10:210-223. http://dx.doi.org/10.1016/j.chom.2011.08.010.
22. Suomalainen M, Nakano MY, Boucke K, Keller S, Stidwill RP, Greber UF. 1999. Microtubule-dependent minus and plus end-directed motilities are competing processes for nuclear targeting of adenovirus. J. Cell Biol. 144:657-672. http://dx.doi.org/10.1083/jcb.144.4.657.
23. Wang IH, Suomalainen M, Andriasyan V, Kilcher S, Mercer J, Neef A, Luedtke NW, Greber UF. 2013. Tracking viral genomes in host cells at single-molecule resolution. Cell Host Microbe 14:468-480. http://dx.doi.org/10.1016/j.chom.2013.09.004.
24. Dazard J-E, Zhang K, Sha J, Yasin O, Cai L, Nguyen C, Ghosh M, Bongorno J, Harter ML. 2011. The dynamics of E1A in regulating networks and canonical pathways in quiescent cells. BMC Res. Notes 4:160. http://dx.doi.org/10.1186/1756-0500-4-160.
25. Pelka P, Ablack JN, Fonseca GJ, Yousef AF, Mymryk JS. 2008. Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J. Virol. 82:7252-7263. http://dx.doi.org/10.1128/JVI.00104-08.
26. Toth K, Wold WS. 2010. Increasing the efficacy of oncolytic adenovirus vectors. Viruses 2:1844-1866. http://dx.doi.org/10.3390/v2091844.
27. Miest TS, Cattaneo R. 2014. New viruses for cancer therapy: meeting clinical needs. Nat. Rev. Microbiol. 12:23-34. http://dx.doi.org/10.1038/nrmicro3140.
28. Toth K, Dhar D, Wold WS. 2010. Oncolytic (replication-competent) adenoviruses as anticancer agents. Expert Opin. Biol. Ther. 10:353-368. http://dx.doi.org/10.1517/14712590903559822.
29. Yakimovich A, Gumpert H, Burckhardt CJ, Lutschg VA, Jurgeit A, Sbalzarini IF, Greber UF. 2012. Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model. J. Virol. 86:10123-10137. http://dx.doi.org/10.1128/JVI.01102-12.
30. Fleischli C, Sirena D, Lesage G, Havenga MJ, Cattaneo R, Greber UF, Hemmi S. 2007. Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J. Gen. Virol. 88:2925-2934. http://dx.doi.org/10.1099/vir.0.83142-0.
31. Lutschg V, Boucke K, Hemmi S, Greber UF. 2011. Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nat. Commun. 2:391. http://dx.doi.org/10.1038/ncomms1391.
32. Nagel H, Maag S, Tassis A, Nestle FO, Greber UF, Hemmi S. 2003. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses. Gene Ther. 10:1643-1653. http://dx.doi.org/10.1038/sj.gt.3302058.
33. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, van Ormondt H, Hoeben RC, van der Eb AJ. 1996. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:215-222. http://dx.doi.org/10.1089/hum.1996.7.2-215.
34. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
35. Louis N, Evelegh C, Graham FL. 1997. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233:423-429. http://dx.doi.org/10.1006/viro.1997.8597.
36. Lee AH, Iwakoshi NN, Glimcher LH. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol. Cell. Biol. 23:7448-7459. http://dx.doi.org/10.1128/MCB.23.21.7448-7459.2003.
37. Greber UF, Webster P, Weber J, Helenius A. 1996. The role of the adenovirus protease on virus entry into cells. EMBO J. 15:1766-1777.
38. Greber UF, Willetts M, Webster P, Helenius A. 1993. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75:477-486. http://dx.doi.org/10.1016/0092-8674(93)90382-Z.
39. Sirena D, Ruzsics Z, Schaffner W, Greber UF, Hemmi S. 2005. The nucleotide sequence and a first generation gene transfer vector of species B human adenovirus serotype 3. Virology 343:283-298. http://dx.doi.org/10.1016/j.virol.2005.08.024.
40. Puntener D, Engelke MF, Ruzsics Z, Strunze S, Wilhelm C, Greber UF. 2011. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells. J. Virol. 85:481-496. http://dx.doi.org/10.1128/JVI.01571-10.
41. Jurgeit A, McDowell R, Moese S, Meldrum E, Schwendener R, Greber UF. 2012. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 8:e1002976. http://dx.doi.org/10.1371/journal.ppat.1002976.
42. Hannus M, Beitzinger M, Engelmann JC, Weickert MT, Spang R, Hannus S, Meister G. 2014. siPools: highly complex but accurately defined siRNA pools eliminate off-target effects. Nucleic Acids Res. 42: 8049-8061. http://dx.doi.org/10.1093/nar/gku480.
43. Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA, Moffat J, Golland P, Sabatini DM. 2006. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7:R100. http://dx.doi.org/10.1186/gb-2006-7-10-r100.
44. Jurgeit A, Moese S, Roulin P, Dorsch A, Lotzerich M, Lee WM, Greber UF. 2010. An RNA replication-center assay for high content image-based quantifications of human rhinovirus and coxsackievirus infections. Virol. J. 7:264. http://dx.doi.org/10.1186/1743-422X-7-264.
45. Spiegel M. 2009. Real-time and dynamic monitoring of virus-mediated cytopathogenicity. Biochemica 3:15-17.
46. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, Nagata K, Harding HP, Ron D. 2004. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18:3066-3077. http://dx.doi.org/10.1101/gad.1250704.
47. Saenz JB, Sun WJ, Chang JW, Li J, Bursulaya B, Gray NS, Haslam DB. 2009. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat. Chem. Biol. 5:157-165. http://dx.doi.org/10.1038/nchembio.144.
48. Hu MC, Hsu MT. 1997. Adenovirus E1B 19K protein is required for efficient DNA replication in U937 cells. Virology 227:295-304. http://dx.doi.org/10.1006/viro.1996.8349.
49. Miller MS, Pelka P, Fonseca GJ, Cohen MJ, Kelly JN, Barr SD, Grand RJ, Turnell AS, Whyte P, Mymryk JS. 2012. Characterization of the 55-residue protein encoded by the 9S E1AmRNAof species C adenovirus. J. Virol. 86:4222-4233. http://dx.doi.org/10.1128/JVI.06399-11.
50. Yoshida K, Higashino F, Fujinaga K. 1995. Transcriptional regulation of the adenovirus E1A gene. Curr. Top. Microbiol. Immunol. 199:113-130.
51. Schmitz M, Graf C, Gut T, Sirena D, Peter I, Dummer R, Greber UF, Hemmi S. 2006. Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa-and fiber-modified replication-competent adenoviruses. Gene Ther. 13:893-905. http://dx.doi.org/10.1038/sj.gt.3302739.
52. Solly K, Wang X, Xu X, Strulovici B, Zheng W. 2004. Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev. Technol. 2:363-372. http://dx.doi.org/10.1089/adt.2004.2.363.
53. van der Linden L, van der Schaar HM, Lanke KH, Neyts J, van Kuppeveld FJ. 2010. Differential effects of the putative GBF1 inhibitors golgicide A and AG1478 on enterovirus replication. J. Virol. 84:7535-7542. http://dx.doi.org/10.1128/JVI.02684-09.
54. Roulin P, Lotzerich M, Tanner LB, Torta FT, van Kuppefeld F, Wenk MR, Greber UF. A phosphatidylinositol 4-phosphate and cholesterol counter-current model for the formation of rhinovirus replication compartments at ER-Golgi interface. Cell Host Microbes, in press.
55. Calfon M, Zeng H, Urano F, Till JH, Hubbard SR, Harding HP, Clark SG, Ron D. 2002. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 415:92-96. http://dx.doi.org/10.1038/415092a.
56. Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. 2007. IRE1 signaling affects cell fate during the unfolded protein response. Science 318:944-949. http://dx.doi.org/10.1126/science.1146361.
57. Cross BC, Bond PJ, Sadowski PG, Jha BK, Zak J, Goodman JM, Silverman RH, Neubert TA, Baxendale IR, Ron D, Harding HP. 2012. The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule. Proc. Natl. Acad. Sci. U. S. A. 109:E869-E878. http://dx.doi.org/10.1073/pnas.1115623109.
58. Tirasophon W, Welihinda AA, Kaufman RJ. 1998. A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 12:1812-1824. http://dx.doi.org/10.1101/gad.12.12.1812.
59. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F. 2002. Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res. 62:3812-3818.
60. Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, Mai J, Shen H, Hu DZ, Adoro S, Hu B, Song M, Tan C, Landis MD, Ferrari M, Shin SJ, Brown M, Chang JC, Liu XS, Glimcher LH. 2014. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature 508:103-107. http://dx.doi.org/10.1038/nature13119.
61. Feng YX, Sokol ES, Del Vecchio CA, Sanduja S, Claessen JH, Proia TA, Jin DX, Reinhardt F, Ploegh HL, Wang Q, Gupta PB. 2014. Epithelialto-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress. Cancer Discov. 4:702-715. http://dx.doi.org/10.1158/2159-8290.CD-13-0945.
62. Rouschop KM, van den Beucken T, Dubois L, Niessen H, Bussink J, Savelkouls K, Keulers T, Mujcic H, Landuyt W, Voncken JW, Lambin P, van der Kogel AJ, Koritzinsky M, Wouters BG. 2010. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. J. Clin. Invest. 120:127-141. http://dx.doi.org/10.1172/JCI40027.
63. Berscheminski J, Groitl P, Dobner T, Wimmer P, Schreiner S. 2013. The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription. J. Virol. 87:965-977. http://dx.doi.org/10.1128/JVI.02023-12.
64. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ. 2008. Adenovirus small e1a alters global patterns of histone modification. Science 321:1084-1085. http://dx.doi.org/10.1126/science.1155544.
65. Schreiner S, Kinkley S, Bürck C, Mund A, Wimmer P, Schubert T, Groitl P, Will H, Dobner T. 2013. SPOC1-mediated antiviral host cell response is antagonized early in human adenovirus type 5 infection. PLoS Pathog. 9:e1003775. http://dx.doi.org/10.1371/journal.ppat.1003775.
66. Mellman I, Coukos G, Dranoff G. 2011. Cancer immunotherapy comes of age. Nature 480:480-489. http://dx.doi.org/10.1038/nature10673.
67. Hendrickx R, Stichling N, Koelen J, Kuryk L, Lipiec A, Greber UF. 2014. Innate immunity to adenovirus. Hum. Gene Ther. 25:265-284. http://dx.doi.org/10.1089/hum.2014.001.
68. Hemminki O, Diaconu I, Cerullo V, Pesonen SK, Kanerva A, Joensuu T, Kairemo K, Laasonen L, Partanen K, Kangasniemi L, Lieber A, Pesonen S, Hemminki A. 2012. Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer. Mol. Ther. 20:1821-1830. http://dx.doi.org/10.1038/mt.2012.115.
69. Han D, Lerner AG, Vande Walle L, Upton J-P, Xu W, Hagen A, Backes BJ, Oakes SA, Papa FR. 2009. IRE1α kinase activation modes control alternate endoribonuclease outputs to determine divergent cell fates. Cell 138:562-575. http://dx.doi.org/10.1016/j.cell.2009.07.017.
70. Hetz C, Martinon F, Rodriguez D, Glimcher LH. 2011. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol. Rev. 91:1219-1243. http://dx.doi.org/10.1152/physrev.00001.2011.
71. Cho JA, Lee AH, Platzer B, Cross BC, Gardner BM, De Luca H, Luong P, Harding HP, Glimcher LH, Walter P, Fiebiger E, Ron D, Kagan JC, Lencer WI. 2013. The unfolded protein response element IRE1alpha senses bacterial proteins invading the ER to activate RIG-I and innate immune signaling. Cell Host Microbe 13:558-569. http://dx.doi.org/10.1016/j.chom.2013.03.011.
72. Fejer G, Drechsel L, Liese J, Schleicher U, Ruzsics Z, Imelli N, Greber UF, Keck S, Hildenbrand B, Krug A, Bogdan C, Freudenberg MA. 2008. Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog. 4:e1000208. http://dx.doi.org/10.1371/journal.ppat.1000208.
73. Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. 2009. Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J. Cell Biol. 186:323-331. http://dx.doi.org/10.1083/jcb.200903014.
74. Upton JP, Wang L, Han D, Wang ES, Huskey NE, Lim L, Truitt M, McManus MT, Ruggero D, Goga A, Papa FR, Oakes SA. 2012. IRE1alpha cleaves select microRNAs during ER stress to derepress translation of proapoptotic caspase-2. Science 338:818-822. http://dx.doi.org/10.1126/science.1226191.